Arti Skin
Food supplement declared in France, declaration No 2021-4-1466, decision dated 26 April 2021
Arti Skin (RLP Concept) is a food supplement declared in France. Status: déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité). None of the rules we check flags an issue with its declared composition; vitamin and mineral doses are not published by Compl'Alim and are therefore not checked.
- Brand
- RLP Concept
- Food business operator placing the product on the market
- RLP CONCEPT
- Status
- Déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité)
- Form
- Poudre
- Daily dose
- 1 cuillere doseuse par jour
- Directions for use
- 1 cuillère doseuse de 6,1 g par jour avant le repas de midi.
- Objectives stated by the manufacturer (these are not authorised claims)
- Peau, Articulations
Declaration 306195, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.
Regulatory points
None of the rules we check applies to the declared ingredients.
Declared composition
Other active ingredients
| Name | Per day |
|---|---|
| Hydrolysat de collagène de poisson | not declared |
| Hyaluronate de sodium | not declared |
| huile de germes de blé | not declared |
| Glucosamine sulfate 2 KCl | not declared |
Vitamins and minerals
Compl'Alim does not publish vitamin and mineral doses. The references below help you read the product label: EFSAEuropean Food Safety Authority. safety limit for adults and maximum dose set in France per product (Order of 9 May 2006, not revised since November 2006).
| Declared form | Nutrient | EFSA limit, adults | Maximum dose in France |
|---|---|---|---|
| Acide orthosilicique stabilisé par de la choline | Silicium | pas de limite (données insuffisantes) | aucune dose fixée |
Additives
E960
Has the product changed? Photograph the packaging.
This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.